Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome

  1. Hernandez-Jerez, A.F.
  2. Adriaanse, P.
  3. Aldrich, A.
  4. Berny, P.
  5. Coja, T.
  6. Duquesne, S.
  7. Focks, A.
  8. Millet, M.
  9. Pelkonen, O.
  10. Pieper, S.
  11. Tiktak, A.
  12. Topping, C.J.
  13. Widenfalk, A.
  14. Wilks, M.
  15. Wolterink, G.
  16. Angeli, K.
  17. Recordati, C.
  18. Van Duursen, M.
  19. Aiassa, E.
  20. Lanzoni, A.
  21. Lostia, A.
  22. Martino, L.
  23. Guajardo, I.P.M.
  24. Panzarea, M.
  25. Terron, A.
  26. Marinovich, M.
  27. Montrer des auteurs +
Revue:
EFSA Journal

ISSN: 1831-4732

Année de publication: 2023

Volumen: 21

Número: 2

Type: Article

DOI: 10.2903/J.EFSA.2023.7744 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus